色素上皮衍生因子治疗年龄相关性黄斑变性的研究进展
Progress on study of treatment of age-related macular degeneration by pigment epithelial-derived factor
摘要
年龄相关性黄斑变性(AMD)是世界范围内老年人致盲的主要疾病之一,探索治疗AMD的有效方法具有防盲治盲的重要意义.色素上皮衍生因子(PEDF)是最强效的内源性新生血管抑制剂,大量基础研究及I期临床试验的结果表明,PEDF可有效治疗以脉络膜新生血管形成为主要特征的湿性AMD,因此,PEDF已成为目前最具潜能的治疗AMD的首选药物之一.
Age-related macular degeneration (AMD) is a common cause of blindness in elderly population.Exploration of effective treatment of AMD has important significance.Pigment epithelial-derived factor (PEDF) is the most powerful endogenous inhibitor of angiogenesis.Increasing evidences,including results of phase I clinical trial,indicated that PEDF could significantly inhibit the development of choroidal neovascularization,which is the characteristic of wet AMD.Therefore,PEDF is one of the most potential therapeutic agents for AMD treatment.
Author:
HOU Hui-yuan
WANG Yu-sheng
作者单位:
第四军医大学西京医院眼科全军眼科研究所,西安,710032
年,卷(期):
2010, 46(2)
分类号:
R77
机标分类号:
R77
TN2
在线出版日期:
2010年5月5日